Skip to main content
NIH funding notice RFA-TR-18-006

NextGen Tissue Chip Testing Centers: Validating Microphysiological Systems (U24 Clinical Trial Not Allowed)

Closed on March 21, 2018.

Posted
December 20, 2017
Close date
March 21, 2018
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,999,568 in first-year total cost, median $1,499,784.

Most frequent study sections

  1. Special Emphasis Panel[ZTR1 DPI-2 (01)]2

Most frequent institutions

  1. MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
  2. TEXAS A&M UNIVERSITY1
Competing awards under RFA-TR-18-006 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2018Translational Center of Tissue Chip Technologies for quantitative characterization of MPS technologies1U24TR002634-01CIRIT, MURATGRODZINSKY, ALAN J.MASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA$1,519,257ZTR1
2018TEX-VAL: Texas A&M Tissue Chip Validation Consortium1U24TR002633-01RUSYN, IVANSTEPHAN, CLIFFORD CTEXAS A&M UNIVERSITY, TX$1,480,311ZTR1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.